ACE2 and COVID-19: The specific mechanism involved in acute hepatic injury in patients with COVID-19 remains unclear, but it is likely multifaceted and multifactorial [12,24].SARS-CoV-2 gains access into the host through the angiotensin-converting enzyme 2 (ACE2) receptor which is present in abundance in cholangiocytes and lesser in hepatocytes.